Related references
Note: Only part of the references are listed.Phase 2B randomized study of nemolizumab in adults with moderate-to-severe atopic dermatitis and severe pruritus
Jonathan Silverberg et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
Efficacy and Safety of Lebrikizumab, a High-Affinity Interleukin 13 Inhibitor, in Adults With Moderate to Severe Atopic Dermatitis A Phase 2b Randomized Clinical Trial
Emma Guttman-Yassky et al.
JAMA DERMATOLOGY (2020)
No evidence of increased cancer incidence in children using topical tacrolimus for atopic dermatitis
Amy S. Paller et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)
Association Between Topical Calcineurin Inhibitor Use and Keratinocyte Carcinoma Risk Among Adults With Atopic Dermatitis
Maryam M. Asgari et al.
JAMA DERMATOLOGY (2020)
Trial of Nemolizumab and Topical Agents for Atopic Dermatitis with Pruritus
Kenji Kabashima et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Treatment of atopic dermatitis with tralokinumab, an anti-IL-13 mAb
Andreas Wollenberg et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
A systematic review and meta-analysis of the regional and age-related differences in atopic dermatitis clinical characteristics
Yik Weng Yew et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2019)
Serlopitant reduced pruritus in patients with prurigo nodularis in a phase 2, randomized, placebo-controlled trial
Sonja Staender et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2019)
Atopic eczema: burden of disease and individual suffering - results from a large EU study in adults
J. Ring et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2019)
The impact of pediatric atopic dermatitis on families: A review
Eric J. Yang et al.
PEDIATRIC DERMATOLOGY (2019)
Corticosteroid phobia (corticophobia) in parents of young children with atopic dermatitis and their health care providers
Bernies Bos et al.
PEDIATRIC DERMATOLOGY (2019)
Atopic Dermatitis: Collegium Internationale Allergologicum (CIA) Update 2019
Dagmar Simon et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2019)
Patient Burden is Associated with Alterations in Quality of Life in Adult Patients with Atopic Dermatitis: Results from the ECLA Study
Laurent Misery et al.
ACTA DERMATO-VENEREOLOGICA (2018)
Epidemiology of atopic dermatitis in adults: Results from an international survey
S. Barbarot et al.
ALLERGY (2018)
Use of systemic corticosteroids for atopic dermatitis: International Eczema Council consensus statement
A. M. Drucker et al.
BRITISH JOURNAL OF DERMATOLOGY (2018)
Patient impact and economic burden of mild-to-moderate atopic dermatitis
Adelaide A. Hebert et al.
CURRENT MEDICAL RESEARCH AND OPINION (2018)
New science and treatment paradigms for atopic dermatitis
James G. Dinulos et al.
CURRENT OPINION IN PEDIATRICS (2018)
Serlopitant for the treatment of chronic pruritus: Results of a randomized, multicenter, placebo-controlled phase 2 clinical trial
Gil Yosipovitch et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2018)
Efficacy and safety of lebrikizumab (an anti-IL-13 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical corticosteroids: A randomized, placebo-controlled phase II trial (TREBLE)
Eric L. Simpson et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2018)
Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: partII
A. Wollenberg et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2018)
Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I
A. Wollenberg et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2018)
Staphylococcus aureus and Atopic Dermatitis: A Complex and Evolving Relationship
Joan A. Geoghegan et al.
TRENDS IN MICROBIOLOGY (2018)
A cohort study on the risk of lymphoma and skin cancer in users of topical tacrolimus, pimecrolimus, and corticosteroids (Joint European Longitudinal Lymphoma and Skin Cancer Evaluation - JOELLE study)
Jordi Castellsague et al.
CLINICAL EPIDEMIOLOGY (2018)
Atopic dermatitis
Stephan Weidinger et al.
NATURE REVIEWS DISEASE PRIMERS (2018)
First-in-human topical microbiome transplantation with Roseomonas mucosa for atopic dermatitis
Ian A. Myles et al.
JCI INSIGHT (2018)
The prevalence of atopic dermatitis beyond childhood: A systematic review and meta-analysis of longitudinal studies
K. Abuabara et al.
ALLERGY (2018)
Environmental risk factors and their role in the management of atopic dermatitis
Robert Kantor et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2017)
Assessment of corticophobia as an indicator of non-adherence to topical corticosteroids: A pilot study
Simon M. Mueller et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2017)
Current guidelines for the evaluation and management of atopic dermatitis: A comparison of the Joint Task Force Practice Parameter and American Academy of Dermatology guidelines
Lawrence F. Eichenfield et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Therapeutic pipeline for atopic dermatitis: End of the drought?
Amy S. Paller et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Increasing Comorbidities Suggest that Atopic Dermatitis Is a Systemic Disorder
Patrick M. Brunner et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2017)
The Burden of Atopic Dermatitis: Summary of a Report for the National Eczema Association
Aaron M. Drucker et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2017)
When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council
Eric L. Simpson et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2017)
Anti-Interleukin-31 Receptor A Antibody for Atopic Dermatitis
Thomas Ruzicka et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Antimicrobials from human skin commensal bacteria protect against Staphylococcus aureus and are deficient in atopic dermatitis
Teruaki Nakatsuji et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Topical Corticosteroid Phobia in Atopic Dermatitis A Systematic Review
Alvin W. Li et al.
JAMA DERMATOLOGY (2017)
Definition of Sensitive Skin: An Expert Position Paper from the Special Interest Group on Sensitive Skin of the International Forum for the Study of Itch
Laurent Misery et al.
ACTA DERMATO-VENEREOLOGICA (2017)
Emerging Treatment Options in Atopic Dermatitis: Topical Therapies
Uffe Nygaard et al.
DERMATOLOGY (2017)
Sensory Neurons Co-opt Classical Immune Signaling Pathways to Mediate Chronic Itch
Landon K. Oetjen et al.
CELL (2017)
Skin absorption through atopic dermatitis skin: a systematic review
A. -S. Halling-Overgaard et al.
BRITISH JOURNAL OF DERMATOLOGY (2017)
The Long-Term Course of Atopic Dermatitis
Katrina Abuabara et al.
DERMATOLOGIC CLINICS (2017)
Mediators of Chronic Pruritus in Atopic Dermatitis: Getting the Itch Out?
Nicholas K. Mollanazar et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2016)
S2k guideline on diagnosis and treatment of atopic dermatitis - short version
Thomas Werfel et al.
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT (2016)
Pathophysiological Study of Sensitive Skin
Virginie Buhe et al.
ACTA DERMATO-VENEREOLOGICA (2016)
Systematic review of published trials: long-term safety of topical corticosteroids and topical calcineurin inhibitors in pediatric patients with atopic dermatitis
Elaine C. Siegfried et al.
BMC PEDIATRICS (2016)
Prevalence and odds of Staphylococcus aureus carriage in atopic dermatitis: a systematic review and meta-analysis
J. E. E. Totte et al.
BRITISH JOURNAL OF DERMATOLOGY (2016)
Topical calcineurin inhibitors in eczema and cancer association: A cohort study
S. C. S. Cai et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2016)
Association of atopic dermatitis with smoking: A systematic review and meta-analysis
Robert Kantor et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2016)
Trying to understand the genetics of atopic dermatitis
Susanne Stemmler et al.
MOLECULAR AND CELLULAR PROBES (2016)
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
E. L. Simpson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Study of the Atopic March: Development of Atopic Comorbidities
Lynda Schneider et al.
PEDIATRIC DERMATOLOGY (2016)
Atopic Dermatitis: Global Epidemiology and Risk Factors
Sophie Nutten
ANNALS OF NUTRITION AND METABOLISM (2015)
Systematic Review on the Efficacy, Safety, and Cost-Effectiveness of Topical Calcineurin Inhibitors in Atopic Dermatitis
Brian Keng Yong Chia et al.
DERMATITIS (2015)
The topical corticosteroid classification called into question: towards a new approach
Philippe Humbert et al.
EXPERIMENTAL DERMATOLOGY (2015)
Atopic Dermatitis in Children Clinical Features, Pathophysiology, and Treatment
Jonathan J. Lyons et al.
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2015)
The Asian atopic dermatitis phenotype combines features of atopic dermatitis and psoriasis with increased TH17 polarization
Shinji Noda et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
Risk of lymphoma in patients with atopic dermatitis and the role of topical treatment: A systematic review and meta-analysis
Laureline Legendre et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2015)
Multi-ancestry genome-wide association study of 21,000 cases and 95,000 controls identifies new risk loci for atopic dermatitis
Lavinia Paternoster et al.
NATURE GENETICS (2015)
Pimecrolimus in atopic dermatitis: Consensus on safety and the need to allow use in infants
Thomas Luger et al.
PEDIATRIC ALLERGY AND IMMUNOLOGY (2015)
Safety and Efficacy of Pimecrolimus in Atopic Dermatitis: A 5-Year Randomized Trial
Bardur Sigurgeirsson et al.
PEDIATRICS (2015)
Translating Atopic Dermatitis Management Guidelines Into Practice for Primary Care Providers
Lawrence F. Eichenfield et al.
PEDIATRICS (2015)
Association Between Malignancy and Topical Use of Pimecrolimus
David J. Margolis et al.
JAMA DERMATOLOGY (2015)
The effect of tacrolimus compared with betamethasone valerate on the skin barrier in volunteers with quiescent atopic dermatitis
S. G. Danby et al.
BRITISH JOURNAL OF DERMATOLOGY (2014)
Skin Barrier Defects in Atopic Dermatitis
Rachana Agrawal et al.
CURRENT ALLERGY AND ASTHMA REPORTS (2014)
Colonization and Infection of the Skin by S. aureus: Immune System Evasion and the Response to Cationic Antimicrobial Peptides
Sunhyo Ryu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
Distinct behavior of human Langerhans cells and inflammatory dendritic epidermal cells at tight junctions in patients with atopic dermatitis
Kazue Yoshida et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)
A sensory neuron-expressed IL-31 receptor mediates T helper cell-dependent itch: Involvement of TRPV1 and TRPA1
Ferda Cevikbas et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)
Guidelines of care for the management of atopic dermatitis Section 2. Management and treatment of atopic dermatitis with topical therapies
Lawrence F. Eichenfield et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2014)
Guidelines of care for the management of atopic dermatitis Section 1. Diagnosis and assessment of atopic dermatitis
Lawrence F. Eichenfield et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2014)
Why we scratch an itch: the molecules, cells and circuits of itch
Diana M. Bautista et al.
NATURE NEUROSCIENCE (2014)
Persistence of Mild to Moderate Atopic Dermatitis
Jacob S. Margolis et al.
JAMA DERMATOLOGY (2014)
Sensitization to Skin-associated Microorganisms in Adult Patients with Atopic Dermatitis is of Importance for Disease Severity
Andreas Sonesson et al.
ACTA DERMATO-VENEREOLOGICA (2013)
Effects of Pimecrolimus Compared with Triamcinolone Acetonide Cream on Skin Barrier Structure in Atopic Dermatitis: A Randomized, Double-blind, Right-Left Arm Trial
Jens-Michael Jensen et al.
ACTA DERMATO-VENEREOLOGICA (2013)
Topical Calcineurin Inhibitors and Lymphoma Risk: Evidence Update with Implications for Daily Practice
Elaine C. Siegfried et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2013)
The effects of pimecrolimus on the innate immune response in atopic dermatitis
S. G. Danby et al.
BRITISH JOURNAL OF DERMATOLOGY (2013)
The Epithelial Cell-Derived Atopic Dermatitis Cytokine TSLP Activates Neurons to Induce Itch
Sarah R. Wilson et al.
CELL (2013)
Differential effects of topical corticosteroid and calcineurin inhibitor on the epidermal tight junction
Sang E. Lee et al.
EXPERIMENTAL DERMATOLOGY (2013)
Mental health comorbidity in patients with atopic dermatitis
Pouya Yaghmaie et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Defects of filaggrin-like proteins in both lesional and nonlesional atopic skin
Laurence Pellerin et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Atopic dermatitis: A practice parameter update 2012
Lynda Schneider et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Staphylococcus δ-toxin induces allergic skin disease by activating mast cells
Yuumi Nakamura et al.
NATURE (2013)
Uptake and Intracellular Trafficking of Superantigens in Dendritic Cells
Maria B. Ganem et al.
PLOS ONE (2013)
Relieving the Pruritus of Atopic Dermatitis: A Meta-analysis
Lindsay G. Sher et al.
ACTA DERMATO-VENEREOLOGICA (2012)
Gene expression is differently affected by pimecrolimus and betamethasone in lesional skin of atopic dermatitis
J. M. Jensen et al.
ALLERGY (2012)
Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis
Heidi H. Kong et al.
GENOME RESEARCH (2012)
Efficacy of pimecrolimus 1 % cream in the long term management of atopic hand dermatitis. A double-blind RCT
Andrea Bauer et al.
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT (2012)
Staphylococcus aureus directly activates eosinophils via platelet-activating factor receptor
Koa Hosoki et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2012)
Increase in short-chain ceramides correlates with an altered lipid organization and decreased barrier function in atopic eczema patients
Michelle Janssens et al.
JOURNAL OF LIPID RESEARCH (2012)
Evaluation of cancer risk related to atopic dermatitis and use of topical calcineurin inhibitors
P. Tennis et al.
BRITISH JOURNAL OF DERMATOLOGY (2011)
Topical corticosteroid phobia in atopic dermatitis: a study of its nature, origins and frequency
H. Aubert-Wastiaux et al.
BRITISH JOURNAL OF DERMATOLOGY (2011)
Differential suppression of epidermal antimicrobial protein expression in atopic dermatitis and in EFAD mice by pimecrolimus compared to corticosteroids
Jens-Michael Jensen et al.
EXPERIMENTAL DERMATOLOGY (2011)
Evaluation of the atrophogenic potential of hydrocortisone 1% cream and pimecrolimus 1% cream in uninvolved forehead skin of patients with atopic dermatitis using optical coherence tomography
Roland Aschoff et al.
EXPERIMENTAL DERMATOLOGY (2011)
Erythrodermic cutaneous T-cell lymphoma: How to differentiate this rare disease from atopic dermatitis
Tomomitsu Miyagaki et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2011)
MECHANISMS OF DISEASE Filaggrin Mutations Associated with Skin and Allergic Diseases
Alan D. Irvine et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Efficacy and tolerance of tacrolimus and pimecrolimus for atopic dermatitis: a meta-analysis
Zhiqiang Yin et al.
JOURNAL OF BIOMEDICAL RESEARCH (2011)
Stratum corneum lipids, skin barrier function and filaggrin mutations in patients with atopic eczema
J. M. Jungersted et al.
ALLERGY (2010)
Is atopic disease a risk factor for attention-deficit/hyperactivity disorder? A systematic review
J. Schmitt et al.
ALLERGY (2010)
Malignancy concerns of topical calcineurin inhibitors for atopic dermatitis: facts and controversies
Diamant Thaci et al.
CLINICS IN DERMATOLOGY (2010)
Innate immunity, allergy and atopic dermatitis
Margarete Niebuhr et al.
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Percutaneous Absorption of Pimecrolimus Is Not Increased in Patients with Moderate to Severe Atopic Dermatitis when Pimecrolimus Cream 1% Is Applied under Occlusion
Diamant Thaci et al.
DERMATOLOGY (2010)
Two topical calcineurin inhibitors for the treatment of atopic dermatitis in pediatric patients: A meta-analysis of randomized clinical trials
Sheng-Li Chen et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2010)
Staphylococcus aureus Extracellular Protease Causes Epidermal Barrier Dysfunction
Yusuke Hirasawa et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
Changes in the Ceramide Profile of Atopic Dermatitis Patients
Junko Ishikawa et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
Targeting the Neurokinin Receptor 1 with Aprepitant: A Novel Antipruritic Strategy
Sonja Staender et al.
PLOS ONE (2010)
Association Between Exposure to Topical Tacrolimus or Pimecrolimus and Cancers
Rita L. Hui et al.
ANNALS OF PHARMACOTHERAPY (2009)
Increased stratum corneum serine protease activity in acute eczematous atopic skin
R. Voegeli et al.
BRITISH JOURNAL OF DERMATOLOGY (2009)
Topical Treatments with Pimecrolimus, Tacrolimus and Medium- to High-Potency Corticosteroids, and Risk of Lymphoma
Sebastian Schneeweiss et al.
DERMATOLOGY (2009)
Different effects of pimecrolimus and betamethasone on the skin barrier in patients with atopic dermatitis (Reprinted from J Allergy Clin Immunol vol 123, pg 1124-33, 2009)
Jens-Michael Jensen et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2009)
Guidelines for management of atopic dermatitis
Hidehisa Saeki et al.
JOURNAL OF DERMATOLOGY (2009)
The Role of Leukocytes, Keratinocytes, and Allergen-Specific IgE in the Development of Atopic Dermatitis
Thomas Werfel
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
The role of Malassezia in atopic dermatitis affecting the head and neck of adults
Kamruz Darabi et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2009)
Pimecrolimus cream 1% in the long-term management of adult atopic dermatitis: prevention of flare progression. A randomized controlled trial
H. Gollnick et al.
BRITISH JOURNAL OF DERMATOLOGY (2008)
Use of topical corticosteroids and topical calcineurin inhibitors for the treatment of atopic dermatitis in thin and sensitive skin areas
Zoe D. Draelos
CURRENT MEDICAL RESEARCH AND OPINION (2008)
The USFDA 'Black box' warning for topical calcineurin inhibitors - An ongoing controversy
Johannes Ring et al.
DRUG SAFETY (2008)
Outside-to-Inside (and now back to Outside) pathogenic mechanisms in atopic dermatitis
Peter M. Elias et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2008)
Long-term management of facial atopic eczema with pimecrolimus cream 1% in paediatric patients with mild to moderate disease
T. Zuberbier et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2008)
StabiEL:: Stabilization of skin condition with Elidel -: a patients' satisfaction observational study addressing the treatment, with pimecrolimus cream, of atopic dermatitis pretreated with topical corticosteroid
Harald Gollnick et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2008)
A randomized controlled trial of pimecrolimus cream 1% in adolescents and adults with head and neck atopic dermatitis and intolerant of, or dependent on, topical corticosteroids
D. F. Murrell et al.
BRITISH JOURNAL OF DERMATOLOGY (2007)
Topical pimecrolimus and tacrolimus transiently induce neuropeptide release and mast cell degranulation in murine skin
S. Staender et al.
BRITISH JOURNAL OF DERMATOLOGY (2007)
Risk factors of atopic dermatitis patients for eczema Herpeticum
Wenming M. Peng et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2007)
Stealth monitoring of adherence to topical medication: Adherence is very poor in children with atopic dermatitis
Jennifer Krejci-Manwaring et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2007)
Risk of lymphoma following exposure to calcineurin inhibitors and topical steroids in patients with atopic dermatitis
Felix M. Arellano et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2007)
Steroid-sparing effect of pimecrolimus cream 1% in children with severe atopic dermatitis
Torsten Zuberbier et al.
DERMATOLOGY (2007)
Loss-of-function mutations in the gene encoding filaggrin cause ichthyosis vulgaris
FJD Smith et al.
NATURE GENETICS (2006)
Onset of pruritus relief with pimecrolimus cream 1% in adult patients with atopic dermatitis: a randomized trial
R Kaufmann et al.
ALLERGY (2006)
Safety and tolerability of 1% pimecrolimus cream among infants: Experience with 1133 patients treated for up to 2 years
C Paul et al.
PEDIATRICS (2006)
Discovery of topical calcineurin inhibitors and pharmacological profile of pimecrolimus
Anton Stuetz et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2006)
Treatment of infants with atopic eczema with pimecrolimus cream 1% improves parents' quality of life:: A multicenter, randomized trial
D Staab et al.
PEDIATRIC ALLERGY AND IMMUNOLOGY (2005)
Pimecrolimus in dermatology: atopic dermatitis and beyond
P Gisondi et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2005)
Mechanisms of action of topical therapies and the rationale for combination therapy
DA Norris
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2005)
The natural course of atopic dermatitis from birth to age 7 years and the association with asthma
S Illi et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2004)
Corticosteroids but not pimecrolimus affect viability, maturation and immune function of murine epidermal Langerhans cells
W Hoetzenecker et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2004)
A randomized investigator-blinded study comparing pimecrolimus cream 1% with tacrolimus ointment 0.03% in the treatment of pediatric patients with moderate atopic dermatitis
S Kempers et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2004)
Effect of pimecrolimus cream 1% on the long-term course of pediatric atopic dermatitis
K Papp et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2004)
Long-term efficacy and safety of pimecrolimus cream 1% in adults with moderate atopic dermatitis
M Meurer et al.
DERMATOLOGY (2004)
Pimecrolimus: A review
AK Gupta et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2003)
Distinct patterns of gene expression in the skin lesions of atopic dermatitis and psoriasis: A gene microarray analysis
L Nomura et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2003)
Skin thickness of Korean adults
Y Lee et al.
SURGICAL AND RADIOLOGIC ANATOMY (2002)
Long-term management of atopic dermatitis in infants with topical pimecrolimus, a nonsteroid anti-inflammatory drug
A Kapp et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2002)
Staphylococcus aureus:: colonizing features and influence of an antibacterial treatment in adults with atopic dermatitis
K Breuer et al.
BRITISH JOURNAL OF DERMATOLOGY (2002)
Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children
U Wahn et al.
PEDIATRICS (2002)
Pimecrolimus cream in the long-term management of atopic dermatitis in adults: A six-month study
M Meurer et al.
DERMATOLOGY (2002)
Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone acetate ointment in children with atopic dermatitis
S Reitamo et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2002)
Pimecrolimus (Elidel, SDZ ASM 981) - Preclinical pharmacologic profile and skin selectivity
A Stuetz et al.
SEMINARS IN CUTANEOUS MEDICINE AND SURGERY (2001)
The new topical ascomycin derivative SDZ ASM 981 does not induce skin atrophy when applied to normal skin for 4 weeks: a randomized, double-blind controlled study
C Queille-Roussel et al.
BRITISH JOURNAL OF DERMATOLOGY (2001)
Topical corticosteroid phobia in patients with atopic eczema
CR Charman et al.
BRITISH JOURNAL OF DERMATOLOGY (2000)
Share Paper
